An evaluation of multiplex bead-based analysis of cytokines and soluble proteins in archived lithium heparin plasma, EDTA plasma and serum samples

References

• Allen C, Duffy S, Teknos T, Islam M, Chen Z, Albert PS, Wolf G, Van Waes C. Nuclear factor-kappaB-related serum factors as longitudinal biomarkers of response and survival in advanced oropharyngeal carcinoma. Clin Cancer Res 2007;13:3182–90.
   PubMed Web of Science ®Google Scholar
• Ang KK, Berkey BA, Tu X, Zhang HZ, Katz R, Hammond EH, Fu KK, Milas L. Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma. Cancer Res 2002;62:7350–6.
   PubMed Web of Science ®Google Scholar
• Byers LA, Holsinger FC, Kies MS, William WN, El-Naggar AK, Lee JJ, Hu J, Lopez A, Tran HT, Yan S, Du Z, Ang KK, Glisson BS, Raso MG, Ii W, Myers JN, Hong WK, Papadimitrakopoulou V, Lippman SM, Heymach JV. Serum signature of hypoxia-regulated factors is associated with progression after induction therapy in head and neck squamous cell cancer. Mol Cancer Ther 2010;9:1755–63.
   PubMed Web of Science ®Google Scholar
• Chen ZY, He WZ, Peng LX, Jia WH, Guo RP, Xia LP, Qian CN. A prognostic classifier consisting of 17 circulating cytokines is a novel predictor of overall survival for metastatic colorectal cancer patients. Int J Cancer 2015;136:584–92.
   PubMed Web of Science ®Google Scholar
• de Jager W, Rijkers GT. Solid-phase and bead-based cytokine immunoassay: a comparison. Methods 2006;38:294–303.
   PubMed Web of Science ®Google Scholar
• Kellar KL, Kalwar RR, Dubois KA, Crouse D, Chafin WD, Kane BE. Multiplexed fluorescent bead-based immunoassays for quantitation of human cytokines in serum and culture supernatants. Cytometry 2001;45:27–36.
   PubMedGoogle Scholar
• Vignali DA. Multiplexed particle-based flow cytometric assays. J Immunol Methods 2000;243:243–55.
   PubMed Web of Science ®Google Scholar
• Spies CM, Straub RH, Cutolo M, Buttgereit F. Circadian rhythms in rheumatology – a glucocorticoid perspective. Arthritis Res Ther 2014;16 Suppl 2:S3
   Google Scholar
• Pahlavani MA, Richardson A. The effect of age on the expression of interleukin-2. Mech Ageing Dev 1996;89:125–54.
   PubMed Web of Science ®Google Scholar
• Khan A. Detection and quantitation of forty-eight cytokines, chemokines, growth factors and nine acute phase proteins in healthy human plasma, saliva and urine. J Proteomics 2012;75:4802–19.
   PubMed Web of Science ®Google Scholar
• Moncunill G, Aponte JJ, Nhabomba AJ, Dobano C. Performance of multiplex commercial kits to quantify cytokine and chemokine responses in culture supernatants from Plasmodium falciparum stimulations. PLoS One 2013;8:e52587.
   Google Scholar
• de Jager W, Bourcier K, Rijkers GT, Prakken BJ, Seyfert-Margolis V. Prerequisites for cytokine measurements in clinical trials with multiplex immunoassays. BMC Immunol 2009;10:52. 2172-10-52.
   PubMed Web of Science ®Google Scholar
• Banks RE. Measurement of cytokines in clinical samples using immunoassays: problems and pitfalls. Crit Rev Clin Lab Sci 2000;37:131–82.
   PubMed Web of Science ®Google Scholar
• Jackman RP, Utter GH, Heitman JW, Hirschkorn DF, Law JP, Gefter N, Busch MP, Norris PJ. Effects of blood sample age at time of separation on measured cytokine concentrations in human plasma. Clin Vaccine Immunol 2011;18:318–26.
   PubMed Web of Science ®Google Scholar
• Friebe A, Volk HD. Stability of tumor necrosis factor alpha, interleukin 6, and interleukin 8 in blood samples of patients with systemic immune activation. Arch Pathol Lab Med 2008;132:1802–6.
   PubMed Web of Science ®Google Scholar
• Parkitny L, McAuley JH, Kelly PJ, Di Pietro F, Cameron B, Moseley GL. Multiplex cytokine concentration measurement: how much do the medium and handling matter? Mediators Inflamm 2013;2013:890706.
   PubMed Web of Science ®Google Scholar
• Keustermans GC, Hoeks SB, Meerding JM, Prakken BJ, de Jager W. Cytokine assays: an assessment of the preparation and treatment of blood and tissue samples. Methods 2013;61:10–7.
   PubMed Web of Science ®Google Scholar
• Flower L, Ahuja RH, Humphries SE, Mohamed-Ali V. Effects of sample handling on the stability of interleukin 6, tumour necrosis factor-alpha and leptin. Cytokine 2000;12:1712–6.
   PubMed Web of Science ®Google Scholar
• De Jongh R, Vranken J, Vundelinckx G, Bosmans E, Maes M, Heylen R. The effects of anticoagulation and processing on assays of IL-6, sIL-6R, sIL-2R and soluble transferrin receptor. Cytokine 1997;9:696–701.
   PubMed Web of Science ®Google Scholar
• Wong HL, Pfeiffer RM, Fears TR, Vermeulen R, Ji S, Rabkin CS. Reproducibility and correlations of multiplex cytokine levels in asymptomatic persons. Cancer Epidemiol Biomarkers Prev 2008;17:3450–6.
   PubMed Web of Science ®Google Scholar
• Ninck S, Reisser C, Dyckhoff G, Helmke B, Bauer H, Herold-Mende C. Expression profiles of angiogenic growth factors in squamous cell carcinomas of the head and neck. Int J Cancer 2003;106:34–44.
   PubMed Web of Science ®Google Scholar
• Kaskas NM, Moore-Medlin T, McClure GB, Ekshyyan O, Vanchiere JA, Nathan CA. Serum biomarkers in head and neck squamous cell cancer. JAMA Otolaryngol Head Neck Surg 2014;140:5–11.
   PubMed Web of Science ®Google Scholar
• Christopoulos A, Ahn SM, Klein JD, Kim S. Biology of vascular endothelial growth factor and its receptors in head and neck cancer: beyond angiogenesis. Head Neck 2011;33:1220–9.
   PubMed Web of Science ®Google Scholar
• de Carvalho TM, Miguel Marin D, da Silva CA, de Souza AL, Talamoni M, Lima CS, Monte Alegre S. Evaluation of patients with head and neck cancer performing standard treatment in relation to body composition, resting metabolic rate, and inflammatory cytokines. Head Neck 2015;37:97–102.
   PubMed Web of Science ®Google Scholar
• Aderhold C, Grobschmidt GM, Sauter A, Faber A, Hormann K, Schultz JD. Interleukin 4, interleukin 6 and osteopontin-serological markers of head and neck malignancy in primary diagnostics: a pilot study. Oncol Lett 2014;8:1112–8.
   PubMed Web of Science ®Google Scholar
• Andersson BA, Lewin F, Lundgren J, Nilsson M, Rutqvist LE, Lofgren S, Laytragoon-Lewin N. Plasma tumor necrosis factor-α and C-reactive protein as biomarker for survival in head and neck squamous cell carcinoma. J Cancer Res Clin Oncol 2014;140:515–9.
   PubMed Web of Science ®Google Scholar
• Kim CH, Lee JS, Kang SO, Bae JH, Hong SP, Kahng H. Serum hepatocyte growth factor as a marker of tumor activity in head and neck squamous cell carcinoma. Oral Oncol 2007;43:1021–5.
   PubMed Web of Science ®Google Scholar
• Lee YC, Yu CC, Lan C, Lee CH, Lee HT, Kuo YL, Wang PH, Chang WW. Plasminogen activator inhibitor-1 as regulator of tumor-initiating cell properties in head and neck cancers. Head Neck 2016; 38:E895–904.
   Google Scholar
• Bentzen J, Toustrup K, Eriksen JG, Primdahl H, Andersen LJ, Overgaard J. Locally advanced head and neck cancer treated with accelerated radiotherapy, the hypoxic modifier nimorazole and weekly cisplatin. Results from the DAHANCA 18 phase II study. Acta Oncol 2015;54:1001–7.
   PubMed Web of Science ®Google Scholar
• Mortensen LS, Johansen J, Kallehauge J, Primdahl H, Busk M, Lassen P, Alsner J, Sørensen BS, Toustrup K, Jakobsen S, Petersen J, Petersen H, Theil J, Nordsmark M, Overgaard J. FAZA PET/CT hypoxia imaging in patients with squamous cell carcinoma of the head and neck treated with radiotherapy: results from the DAHANCA 24 trial. Radiother Oncol 2012;105:14–20.
   PubMed Web of Science ®Google Scholar
• Lonbro S, Dalgas U, Primdahl H, Johansen J, Nielsen JL, Aagaard P, Hermann AP, Overgaard J, Overgaard K. Progressive resistance training rebuilds lean body mass in head and neck cancer patients after radiotherapy – results from the randomized DAHANCA 25B trial. Radiother Oncol 2013;108:314–9.
   PubMed Web of Science ®Google Scholar
• Kenis G, Teunissen C, De Jongh R, Bosmans E, Steinbusch H, Maes M. Stability of interleukin 6, soluble interleukin 6 receptor, interleukin 10 and CC16 in human serum. Cytokine 2002;19:228–35.
   PubMed Web of Science ®Google Scholar
• Thavasu PW, Longhurst S, Joel SP, Slevin ML, Balkwill FR. Measuring cytokine levels in blood. Importance of anticoagulants, processing, and storage conditions. J Immunol Methods 1992;153:115–24.
   PubMed Web of Science ®Google Scholar
• Hosnijeh FS, Krop EJ, Portengen L, Rabkin CS, Linseisen J, Vineis P, Vermeulen R. Stability and reproducibility of simultaneously detected plasma and serum cytokine levels in asymptomatic subjects. Biomarkers 2010;15:140–8.
   PubMed Web of Science ®Google Scholar
• Aziz N, Nishanian P, Mitsuyasu R, Detels R, Fahey JL. Variables that affect assays for plasma cytokines and soluble activation markers. Clin Diagn Lab Immunol 1999;6:89–95.
   PubMedGoogle Scholar
• Sennels HP, Jacobsen S, Jensen T, Hansen MS, Ostergaard M, Nielsen HJ, Sørensen S. Biological variation and reference intervals for circulating osteopontin, osteoprotegerin, total soluble receptor activator of nuclear factor kappa B ligand and high-sensitivity C-reactive protein. Scand J Clin Lab Invest 2007;67:821–35.
   PubMed Web of Science ®Google Scholar
• Clendenen TV, Arslan AA, Lokshin AE, Idahl A, Hallmans G, Koenig KL, Marrangoni AM, Nolen BM, Ohlson N, Zeleniuch-Jacquotte A, Lundin E. Temporal reliability of cytokines and growth factors in EDTA plasma. BMC Res Notes 2010;3:302.
   PubMedGoogle Scholar
• Biancotto A, Feng X, Langweiler M, Young NS, McCoy JP. Effect of anticoagulants on multiplexed measurement of cytokine/chemokines in healthy subjects. Cytokine 2012;60:438–46.
   PubMed Web of Science ®Google Scholar
• Burska A, Boissinot M, Ponchel F. Cytokines as biomarkers in rheumatoid arthritis. Mediators Inflamm 2014;2014:545493.
   PubMed Web of Science ®Google Scholar
• Lanteri P, Lombardi G, Colombini A, Grasso D, Banfi G. Stability of osteopontin in plasma and serum. Clin Chem Lab Med 2012;50:1979–84.
   PubMed Web of Science ®Google Scholar
• Capila I, Linhardt RJ. Heparin-protein interactions. Angew Chem Int Ed Engl 2002;41:391–412.
   PubMed Web of Science ®Google Scholar
• Zimmermann R, Ringwald J, Eckstein R. EDTA plasma is unsuitable for in vivo determinations of platelet-derived angiogenic cytokines. J Immunol Methods 2009;347:91–2.
   PubMed Web of Science ®Google Scholar